The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
ARVN · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
RLAY · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | KYNB | ARVN | RLAY | SRTA |
|---|---|---|---|---|
| Moat Score (0–100) | 33 | 34 (highest) | 34 (highest) | 33 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 35 | 55 | 55 | 75 (highest) |
| Pricing power | 81 (highest) | — | — | 13 |
| Returns on capital | 0 (highest) | 0 (highest) | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 28 | 55 (highest) | 55 (highest) | 55 (highest) |
| Capital allocation | 24 (highest) | 24 (highest) | 24 (highest) | 24 (highest) |
| No price data | No price data | No price data | No price data | |
| Market cap | $19.6M | $443M | $2.8B | $395M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |